OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
Eline Schillebeeckx, Jan P. van Meerbeeck, Kevin Lamote
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 210057-210057
Open Access | Times Cited: 40
Eline Schillebeeckx, Jan P. van Meerbeeck, Kevin Lamote
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 210057-210057
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
Rapid diagnosis of malignant pleural mesothelioma and its discrimination from lung cancer and benign exudative effusions using blood serum
Dilek Yonar, Mete Severcan, Rafig Gurbanov, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 10, pp. 166473-166473
Open Access | Times Cited: 24
Dilek Yonar, Mete Severcan, Rafig Gurbanov, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 10, pp. 166473-166473
Open Access | Times Cited: 24
Decoding myasthenia gravis: advanced diagnosis with infrared spectroscopy and machine learning
Feride Severcan, Ipek Ozyurt, Ayça Doğan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Feride Severcan, Ipek Ozyurt, Ayça Doğan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma
Berta Mosleh, Katharina Sinn, Anna Cho, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1371-1371
Open Access
Berta Mosleh, Katharina Sinn, Anna Cho, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1371-1371
Open Access
From asbestos exposure to carcinogenesis: Transcriptomic signatures in malignant pleural mesothelioma
Diletta Rosati, Bianca Giulia Maurizi, Viola Bianca Serio, et al.
Experimental and Molecular Pathology (2025) Vol. 143, pp. 104973-104973
Open Access
Diletta Rosati, Bianca Giulia Maurizi, Viola Bianca Serio, et al.
Experimental and Molecular Pathology (2025) Vol. 143, pp. 104973-104973
Open Access
Gold(III) complexes with thiosemicarbazone ligands: insights into their cytotoxic effects on lung cancer cells
Mirco Scaccaglia, Silvana Pinelli, Luca Manini, et al.
Journal of Inorganic Biochemistry (2023) Vol. 251, pp. 112438-112438
Open Access | Times Cited: 9
Mirco Scaccaglia, Silvana Pinelli, Luca Manini, et al.
Journal of Inorganic Biochemistry (2023) Vol. 251, pp. 112438-112438
Open Access | Times Cited: 9
DHEA-S, Androstenedione, 17-β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigation
Barbara Nuvoli, Andrea Sacconi, Grazia Bottillo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116662-116662
Closed Access | Times Cited: 3
Barbara Nuvoli, Andrea Sacconi, Grazia Bottillo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116662-116662
Closed Access | Times Cited: 3
Exploring RNA cargo in extracellular vesicles for pleural mesothelioma detection
Agnieszka Kraft, Michaela B. Kirschner, V. Orlowski, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Agnieszka Kraft, Michaela B. Kirschner, V. Orlowski, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
Claudio Sorino, Michele Mondoni, Giampietro Marchetti, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 22, pp. 7006-7006
Open Access | Times Cited: 8
Claudio Sorino, Michele Mondoni, Giampietro Marchetti, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 22, pp. 7006-7006
Open Access | Times Cited: 8
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research
Eline Janssens, Zoë Mol, Lore Vandermeersch, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Eline Janssens, Zoë Mol, Lore Vandermeersch, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Diversity of the Circulating Tumor Markers: Perspectives of a Multimodal Liquid Biopsy
Ekatherina Sh. Kuligina, Grigoriy A. Yanus, Evgeny N. Imyanitov
Biochemistry (Moscow) (2024) Vol. 89, Iss. 11, pp. 1985-1997
Closed Access | Times Cited: 2
Ekatherina Sh. Kuligina, Grigoriy A. Yanus, Evgeny N. Imyanitov
Biochemistry (Moscow) (2024) Vol. 89, Iss. 11, pp. 1985-1997
Closed Access | Times Cited: 2
The Use of Chest Magnetic Resonance Imaging in Malignant Pleural Mesothelioma Diagnosis
Federica Volpi, Caterina Aida D’Amore, Leonardo Colligiani, et al.
Diagnostics (2022) Vol. 12, Iss. 3, pp. 750-750
Open Access | Times Cited: 9
Federica Volpi, Caterina Aida D’Amore, Leonardo Colligiani, et al.
Diagnostics (2022) Vol. 12, Iss. 3, pp. 750-750
Open Access | Times Cited: 9
Mesotelioma pleural
José M. Porcel
Medicina Clínica (2022) Vol. 159, Iss. 5, pp. 240-247
Closed Access | Times Cited: 8
José M. Porcel
Medicina Clínica (2022) Vol. 159, Iss. 5, pp. 240-247
Closed Access | Times Cited: 8
The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling
Roshini Arivazhagan, Chandra Goparaju, Somanath Kundu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Roshini Arivazhagan, Chandra Goparaju, Somanath Kundu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
New Markers for Management of Mesothelioma
Alistair Nash, Tina Firth née Phan, Jenette Creaney
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 04, pp. 491-501
Closed Access | Times Cited: 4
Alistair Nash, Tina Firth née Phan, Jenette Creaney
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 04, pp. 491-501
Closed Access | Times Cited: 4
Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results
Kathleen Zwijsen, Eline Schillebeeckx, Eline Janssens, et al.
Journal of Breath Research (2023) Vol. 17, Iss. 4, pp. 047105-047105
Open Access | Times Cited: 4
Kathleen Zwijsen, Eline Schillebeeckx, Eline Janssens, et al.
Journal of Breath Research (2023) Vol. 17, Iss. 4, pp. 047105-047105
Open Access | Times Cited: 4
[Advances in Targeted Therapy for Malignant Pleural Mesothelioma].
Fen Fu, Yang Zhang, Hong Shen
PubMed (2024) Vol. 27, Iss. 5, pp. 391-398
Closed Access | Times Cited: 1
Fen Fu, Yang Zhang, Hong Shen
PubMed (2024) Vol. 27, Iss. 5, pp. 391-398
Closed Access | Times Cited: 1
Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review
Aliakbar Ebrahimi, Güntülü Ak, Ceren Özel, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 11, pp. 3299-3333
Open Access | Times Cited: 1
Aliakbar Ebrahimi, Güntülü Ak, Ceren Özel, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 11, pp. 3299-3333
Open Access | Times Cited: 1
Identification of Highly Sensitive Pleural Effusion Protein Biomarkers for Malignant Pleural Mesothelioma by Affinity-Based Quantitative Proteomics
Nicolai Bjødstrup Palstrøm, Martin Overgaard, Peter B. Licht, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 641-641
Open Access | Times Cited: 3
Nicolai Bjødstrup Palstrøm, Martin Overgaard, Peter B. Licht, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 641-641
Open Access | Times Cited: 3
Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma
Elisabeth Digifico, Marco Erreni, Laura Mannarino, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Elisabeth Digifico, Marco Erreni, Laura Mannarino, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Pleural inflammatory response, mesothelin content and DNA damage in mice at one-year after intra-pleural carbon nanotube administration
Regitze Sølling Wils, Nicklas Raun Jacobsen, Ulla Vogel, et al.
Toxicology (2023) Vol. 499, pp. 153662-153662
Open Access | Times Cited: 3
Regitze Sølling Wils, Nicklas Raun Jacobsen, Ulla Vogel, et al.
Toxicology (2023) Vol. 499, pp. 153662-153662
Open Access | Times Cited: 3
Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma
Cita Zupanc, Alenka Franko, Danijela Štrbac, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 190-190
Open Access | Times Cited: 3
Cita Zupanc, Alenka Franko, Danijela Štrbac, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 190-190
Open Access | Times Cited: 3
External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma
Eline Janssens, Eline Schillebeeckx, Kathleen Zwijsen, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3182-3182
Open Access | Times Cited: 5
Eline Janssens, Eline Schillebeeckx, Kathleen Zwijsen, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3182-3182
Open Access | Times Cited: 5
Serum diagnostic markers for malignant pleural mesothelioma: a narrative review
Jingjing Wang, Yan Li
Translational Cancer Research (2022) Vol. 11, Iss. 12, pp. 4434-4440
Open Access | Times Cited: 4
Jingjing Wang, Yan Li
Translational Cancer Research (2022) Vol. 11, Iss. 12, pp. 4434-4440
Open Access | Times Cited: 4
Asbestos-related Cancer: Exaggerated Risk Perception
Sergei V. Jargin
Cancer Screening and Prevention (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Sergei V. Jargin
Cancer Screening and Prevention (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
